Publications
  
  
  
Please enter only numerical values
  
  
Cancer Cell 2024
Kim KH., Migliozzi S., Koo H., Hong JH., et al. (2024). Integrated proteogenomic characterization of glioblastoma evolution. Cancer cell, S1535-6108(23)00443-9.
Cell Reports Medicine 2024
Li GX., Chen L., Hsiao Y., Mannan R., et al. (2024). Comprehensive proteogenomic characterization of rare kidney tumors. Cell Reports Medicine 5, 101547. https://doi.org/10.1016/j.xcrm.2024.101547
Cell Reports Medicine 2024
Pino, J.C., Posso, C., Joshi, S.K., Nestor, M., et al. (2024) Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia. Cell Reports Medicine Vol. 5(1), 101359
Clin Proteomics 2024
Savage, S.R., Wang, Y., Chen, L., Jewell, S., et al. (2024). Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma. Clin. Proteom., 21(7).
Mol Cell Proteomics 2024
Lih TM., Cao L., Minoo P., Omenn GS., et al. (2024). Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. Mol Cell Proteomics 23(1).
Cancer Cell 2024
Liu J., Cao S., Imbach KJ., Gritsenko MA., et al. (2024). Multi-scale signaling and tumor evolution in high-grade gliomas. Cancer Cell 42(7) 1217-1238.
Cancer Cell 2023
Dou ,Y., Katsnelson, L., Gritsenko, M.A., Hu, Y., et al. (2023). Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer Cell, 41, 1-20.
Nat Cancer 2023
Hyeon DY., Nam D., Han Y., Kim DK., Kim G., et al. (2023). Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes. Nat Cancer 4, 290-307. doi: 10.1038/s43018-022-00479-7
Cell 2023
Chowdhury, S., Kennedy, J.J., Ivey, R.G., Murillo, O.D., et al. (2023). Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell, 186(16), 3476-3498.e35.
Gastroenterology 2023
Cho SY., Hwang H., Kim YH., Yoo BC., et al. (2023). Refining Classification of Cholangiocarcinoma Subtypes via Proteogenomic Integration Reveals New Therapeutic Prospects. Gastroenterology, 41(7), 1293-1309.
Cell Reports 2023
Lih TM., Cho KC., Schnaubelt M., Hu Y., Zhang H. (2023). Integrated glycoproteomic characterization of clear cell renal cell carcinoma. Cell Reports 42(5):112409. https://doi.org/10.1016/j.celrep.2023.112409
Cancer Cell 2022
Li Y., Lih TM., Dhanasekaran SM., Mannan R., Chen L, Cieslik M, et al. (2022). Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 45, 1-25. https://doi.org/10.1016/j.ccell.2022.12.001
Clin Proteomics 2022
Li, Q.K., Hu, Y., Chen, L., Schnaubelt, M., et al. (2022). Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma. Clin. Proteom., 19(36).
Cancer Discovery 2022
Anurag M., Jaehnig EJ., Krug K., Lei JT., et al. (2022). Proteogenomic markers of chemotherapy resistance and response in triple negative breast cancer. Cancer Discov., CD-22-0200. https://doi.org/10.1158/2159-8290.cd-22-0200
Clin Proteomics 2022
Gosline, S.J.C., Tognon, C., Nestor, M., Joshi S., et al. (2022). Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML, Clin. Proteom., 19(30).
Cell Reports Medicine 2022
Soltis, A.R., Bateman, N.W., Liu, J., Nguyen, T., et al. (2022). Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. Cell Reports Medicine, 3(11).
Cell 2021
Satpathy, S., Krug, K., Jean Beltran, P.M., Savage, S.R., et al. (2021). A Proteogenomic Portrait of Lung Squamous Cell Carcinoma. Cell, Vol. 184, 16, p4348-4371.e40. https://doi.org/10.1016/j.cell.2021.07.016
Cancer Cell 2021
Huang, C., Chen, L., Savage, S.R., Eguez, R.V., Dou, Y., Li, Y., et al. (2021). Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer cell, 39(3), 361-379.e16.
Cancer Cell 2021
Wang, L.B., Karpova, A., Gritsenko, M.A., Kyle, J.E., Cao, S., Li, Y., et al. (2021). Proteogenomic and metabolomic characterization of human glioblastoma. Cancer cell. doi:10.1016/j.ccell.2021.01.006
Cell 2021
Cao L., Huang C., Zhou D.C., Hu Y., et al. (2021). Proteogenomic characterization of pancreatic ductal adenocarcinoma, Cell, 184(19), 5031-52.
Cancer Cell 2021
Joshi, S.K., Nechiporuk, T., Bottomly, D., Piehowski, P.D., Reisz, J.A., Pittsenbarger, J., et al., (2021). The AML Microenvironment Catalyzes a Step-wise Evolution to Gilteritinib Resistance. Cancer Cell. https://doi.org/10.1016/j.ccell.2021.06.003
Cell 2020
Krug, K., Jaehnig, E.J., Satpathy, S., Blumenberg, L., Karpova, A., Anurag, M., et al. (2020). Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy. Cell, 183(5), 1436-1456.e31.
Cell 2020
Dou, Y., Kawaler, E.A., Cui Zhou, D., Gritsenko, M.A., Huang, C., Blumenberg, L., et al. (2020). Proteogenomic Characterization of Endometrial Carcinoma. Cell, 180(4), 729-748.e26.
Anal. Chem. 2020
Cho KC, Clark DJ, Schnaubelt M, Teo GC, et al. (2020). Anal. Chem., 92(6), 4217-25.
Cell 2020
Chen, Y.J., Roumeliotis, T.I., Chang, Y.H., Chen, C.T., Han, C.L., Lin, M.H., et al. (2020). Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression. Cell, 182(1), 226-244.e17.
Cell 2020
Gillette, M.A., Satpathy, S., Cao, S., Dhanasekaran, S.M., Vasaikar, S.V., Krug, K., et al. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell, 182(1), 200-225.e35.
Cell Rep Med 2020
McDermott, J.E., Arshad, O.A., Petyuk, V.A., Fu, Y., Gritsenko, M.A., Clauss, T.R., et al. (2020). Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability. Cell reports. Medicine, 1(1), 100004.
Nature Communications 2020
Satpathy, S., Jaehnig, E.J., Krug, K. et al. (2020). Microscaled proteogenomic methods for precision oncology. Nature Communications, Vol. 11,1 532. https://doi.org/10.1038/s41467-020-14381-2
Cell Rep 2020
Hu, Y., Pan, J., Shah, P., Ao, M., Thomas, S.N., Liu, Y., et al. (2020). Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma. Cell reports, 33(3), 108276.
Cell 2020
Petralia, F., Tignor, N., Reva, B., Koptyra, M., Chowdhury, S., Rykunov, D., et al. (2020). Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell, 183(7), 1962-1985.e31.
Cell 2019
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., et al. (2019). Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell, 179(2), 561-577.e22.
Cell 2019
Vasaikar, S., Huang, C., Wang, X., Petyuk, V. A., Savage, S. R., Wen, B., et al. (2019). Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities. Cell, 177(4), 1035-1049.e19. https://doi.org/10.1016/j.cell.2019.03.030
Cell 2019
Clark, D.J., Dhanasekaran, S.M., Petralia, F., Pan, J., Song, X., Hu, Y., et al. (2019). Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell, 179(4), 964-983.e31.
Cancer Cell 2019
Mun, D.G., Bhin, J., Kim, S., Kim, H., Jung, J.H., Jung, Y., et al. (2019). Proteogenomic Characterization of Human Early-Onset Gastric Cancer. Cancer cell, 35(1), 111-124.e10.
Nature protocols 2018
Mertins, P., Tang, L.C., Krug, K., et al. (2018). Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry. Nat Protocols,13(7) p1632-1661. https://doi.org/10.1038/s41596-018-0006-9
Journal of Proteome Research 2018
Clark, D. J., Hu, Y., Bocik, W., Chen, L., Schnaubelt, M., Roberts, R., Shah, P., Whiteley, G., & Zhang, H. (2018). Evaluation of NCI-7 Cell Line Panel as a Reference Material for Clinical Proteomics. Journal of proteome research, 17(6), 2205-2215. https://doi.org/10.1021/acs.jproteome.8b00165
Cancer Research 2018
Mundt, F., Rajput, S., et al. (2018). Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers. Cancer research, 78(10), 2732-2746. https://doi.org/10.1158/0008-5472.CAN-17-1990
Cancer Cell 2018
Archer, TC., Ehrenberger, T., Mundt, F., Gold, MP., Krug, K., Mah, CK., et al. (2018). Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer cell, 34(1), 396-410.e8.
Nat Commun 2017
Chen, T.W., Lee, C.C., Liu, H., Wu, C.S., Pickering, C.R., Huang, P.J., et al. (2017). APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism. Nature communications, 8(1), 465.
Nature Communications 2017
Huang, K. L., Li, S., Mertins, P., Cao, S., Gunawardena, H. P., Ruggles, K. V., et al. (2017). Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nature communications, 8, 14864. https://doi.org/10.1038/ncomms14864
Cell 2016
Zhang, H., Liu, T., Zhang, Z., Payne, S.H., Zhang, B., McDermott, J.E., et al. (2016). Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell, 166(3), 755-65.
Nature 2016
Mertins, P., Mani, D.R., Ruggles, K.V., Gillette, M.A., et al. (2016). Proteogenomics connects somatic mutations to signalling in breast cancer. Nature, 534(7605), 55-62.
Sci Data 2015
Slebos, R.J., Wang, X., Wang, X., Wang, X., Zhang, B., Tabb, D.L., & Liebler, D.C. (2015). Proteomic analysis of colon and rectal carcinoma using standard and customized databases. Scientific data, 2, 150022.
Nat Med 2015
Guo, T., Kouvonen, P., Koh, C.C., et al. (2015). Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nature medicine, 21(4), 407-13.
Nature 2014
Zhang, B., et al. (2014). Proteogenomic characterization of human colon and rectal cancer. Nature, 513(7518), 382-7.
Warning